Go Pro

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Mosaic ImmunoEngineering Inc. stock logo
CPMV
Mosaic ImmunoEngineering
$0.06
$0.46
$0.05
$1.05
$440K-0.82812 shs4 shs
LIFE
Ethos Technologies Inc. Class A Common Stock
$38.64
-2.0%
$24.74
$9.45
$40.97
$2.46BN/A1.82 million shs1.09 million shs
Don't Wait for the OpenAI IPO Cover

The AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Mosaic ImmunoEngineering Inc. stock logo
CPMV
Mosaic ImmunoEngineering
0.00%0.00%+12.96%-84.24%-88.64%
LIFE
Ethos Technologies Inc. Class A Common Stock
0.00%+13.11%+90.63%+104.44%+3,863,999,900.00%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Mosaic ImmunoEngineering Inc. stock logo
CPMV
Mosaic ImmunoEngineering
$0.06
$0.46
$0.05
$1.05
$440K-0.82812 shs4 shs
LIFE
Ethos Technologies Inc. Class A Common Stock
$38.64
-2.0%
$24.74
$9.45
$40.97
$2.46BN/A1.82 million shs1.09 million shs
Don't Wait for the OpenAI IPO Cover

The AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Mosaic ImmunoEngineering Inc. stock logo
CPMV
Mosaic ImmunoEngineering
0.00%0.00%+12.96%-84.24%-88.64%
LIFE
Ethos Technologies Inc. Class A Common Stock
0.00%+13.11%+90.63%+104.44%+3,863,999,900.00%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Mosaic ImmunoEngineering Inc. stock logo
CPMV
Mosaic ImmunoEngineering
0.00
N/AN/AN/A
LIFE
Ethos Technologies Inc. Class A Common Stock
2.71
Moderate Buy$32.29-16.44% Downside

Current Analyst Ratings Breakdown

Latest LIFE and CPMV Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
8/21/2026
LIFE
Ethos Technologies Inc. Class A Common Stock
Reiterated RatingSell (D)
8/4/2026
LIFE
Ethos Technologies Inc. Class A Common Stock
Set Price Target$33.00
8/4/2026
LIFE
Ethos Technologies Inc. Class A Common Stock
Reiterated RatingMarket Outperform
8/4/2026
LIFE
Ethos Technologies Inc. Class A Common Stock
Reiterated RatingBuy$35.00
8/4/2026
LIFE
Ethos Technologies Inc. Class A Common Stock
Boost Price TargetBuy$27.00 ➝ $33.00
8/4/2026
LIFE
Ethos Technologies Inc. Class A Common Stock
Boost Price TargetMarket Outperform$27.00 ➝ $33.00
8/4/2026
LIFE
Ethos Technologies Inc. Class A Common Stock
Boost Price TargetOverweight$27.00 ➝ $37.00
8/4/2026
LIFE
Ethos Technologies Inc. Class A Common Stock
Boost Price TargetOutperform$26.00 ➝ $32.00
7/13/2026
LIFE
Ethos Technologies Inc. Class A Common Stock
Boost Price TargetOverweight$21.50 ➝ $23.00
(Data available from 8/30/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Mosaic ImmunoEngineering Inc. stock logo
CPMV
Mosaic ImmunoEngineering
N/AN/AN/AN/A($1.08) per shareN/A
LIFE
Ethos Technologies Inc. Class A Common Stock
$387.61M6.36$1.22 per share31.72$7.47 per share5.17
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Mosaic ImmunoEngineering Inc. stock logo
CPMV
Mosaic ImmunoEngineering
-$690K-$0.09N/AN/AN/AN/AN/A-3,108.08%N/A
LIFE
Ethos Technologies Inc. Class A Common Stock
$71.15M-$2.85N/A30.43N/AN/AN/AN/AN/A

Latest LIFE and CPMV Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/14/2026Q2 2026
Mosaic ImmunoEngineering Inc. stock logo
CPMV
Mosaic ImmunoEngineering
N/A-$0.02N/A-$0.02N/AN/A
8/3/2026Q2 2026
LIFE
Ethos Technologies Inc. Class A Common Stock
$0.19$0.53+$0.34$0.30N/A$189.56 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Mosaic ImmunoEngineering Inc. stock logo
CPMV
Mosaic ImmunoEngineering
N/AN/AN/AN/AN/A
LIFE
Ethos Technologies Inc. Class A Common Stock
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Mosaic ImmunoEngineering Inc. stock logo
CPMV
Mosaic ImmunoEngineering
N/AN/AN/A
LIFE
Ethos Technologies Inc. Class A Common Stock
N/A
4.18
4.18

Institutional Ownership

CompanyInstitutional Ownership
Mosaic ImmunoEngineering Inc. stock logo
CPMV
Mosaic ImmunoEngineering
N/A
LIFE
Ethos Technologies Inc. Class A Common Stock
61.72%

Insider Ownership

CompanyInsider Ownership
Mosaic ImmunoEngineering Inc. stock logo
CPMV
Mosaic ImmunoEngineering
80.99%
LIFE
Ethos Technologies Inc. Class A Common Stock
3.70%
CompanyEmployeesShares OutstandingFree FloatOptionable
Mosaic ImmunoEngineering Inc. stock logo
CPMV
Mosaic ImmunoEngineering
37.24 million1.38 millionNot Optionable
LIFE
Ethos Technologies Inc. Class A Common Stock
61463.76 million61.40 millionN/A

Recent News About These Companies

Ethos Technologies advances 24% after strong results

New MarketBeat Followers Over Time

Media Sentiment Over Time

Mosaic ImmunoEngineering stock logo

Mosaic ImmunoEngineering OTCMKTS:CPMV

$0.06 0.00 (0.00%)
As of 08/28/2026

Mosaic ImmunoEngineering, Inc., a development-stage biotechnology company, focuses on developing and commercializing immunomodulator platform technology for the treatment of cancer and infectious diseases in humans and for veterinary use. Its lead immunotherapy product candidate, MIE-101, a nanoparticle-based treatment derived from cowpea mosaic virus, which is non-infectious in humans and animals. The company was founded in 2020 and is based in Novato, California.

Ethos Technologies Inc. Class A Common Stock NASDAQ:LIFE

$38.64 -0.80 (-2.03%)
As of 08/28/2026 04:00 PM Eastern

Ethos Technologies Inc operates a technology-driven, direct-to-consumer platform for the distribution of life insurance products. Through its digital underwriting, data analytics, and proprietary technology, it enables consumers to explore, compare, and purchase life insurance policies online. The platform serves consumers, agents, and insurance carriers, and supports the application and policy issuance process through an online interface. The company works with insurance carriers to offer life insurance products in the United States through digital channels and independent agents. It generates revenue through commissions paid by carriers from policies activated and sold through its platform as well as from the provision of third-party administrator services for such policies.